Summary
MDY, the Aim-listed health care investor, has snapped up a 1.21 per cent stake in Borders pharmaceutical firm ProStrakan from private equity group 3i.
London-based MDY said it had bought the 2.4 million shares as part of a portfolio of healthcare assets for about GBP 3 million in cash and new shares.See the full content of this document
Extract
Need to Know: Mdy in Gbp 3m Swoop On Prostrakan
David Won...
See the full content of this document
Sponsored links
